MHRA Drug Safety Update September 2019

MHRA Drug Safety Update September 2019

September 19, 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 1 August 2019) has been published and includes articles on:

  • Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping
  • Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception
  • Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy
  • Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions
  • Letters and drug alerts sent to healthcare professionals in August 2019
  • Medical Device Alerts issued in August 2019

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >